Product Reports Resources Pricing Login Book a demo

Crinetics Pharmaceuticals

Biotech & Life Sciences · San Diego, United States · Founded 2008 · IPO 2018

Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company specializing in the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company operates in the biopharmaceutical market, targeting conditions that have limited treatment options. Crinetics serves patients with rare endocrine disorders, such as acromegaly, by developing innovative oral treatments like CRN00808, which is currently in Phase 2 clinical trials. The business model focuses on advancing drug candidates through clinical trials and obtaining regulatory approvals to bring these therapies to market. Revenue is generated through the commercialization of approved drugs and potential partnerships or licensing agreements with larger pharmaceutical companies. Keywords: endocrine diseases, rare disorders, novel therapeutics, clinical trials, drug discovery, acromegaly, oral treatments, biopharmaceutical, GPCRs, commercialization.

Valuation $7.60B
Revenue $7.7M
Total funding $100–500M
Power Law Unicorn$1–10B valuation tier
Featured in
News Vertex to buy Crinetics for $10B, adding endocrine drugs Jul 7, 2026

Investors

20 investors on Crinetics Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 2 investors entered at this stage
National Institutes of Health
National Eye Institute
Series A 6 investors entered at this stage
5AM Ventures
Vivo Capital
Versant Ventures
Perceptive Advisors
RA Capital Management
OrbiMed
Series B+ 12 investors entered at this stage
Adage Capital
EcoR1 Capital
Invus
Janus Henderson Investors
OrbiMed
Driehaus Capital Management
GordonMD Global Investment
First Light Asset Management
Paradigm BioCapital
Perceptive Advisors
Rock Springs Capital
RA Capital Management

Global footprint

Where Crinetics Pharmaceuticals has talent and traffic

Workforce by country
9 countries with
team presence
🇺🇸 United States95.7%
🇩🇪 Germany1.3%
🇨🇭 Switzerland1.1%
🇧🇷 Brazil0.8%
🇳🇱 Netherlands0.2%
Top 5 of 9 shown
Web traffic by country
15K monthly visits
across markets
🇺🇸 United States61.3%
🇮🇳 India11.3%
🇬🇧 United Kingdom9.3%
🇭🇷 Croatia5.3%
🇩🇪 Germany4.7%
Top 5 markets shown

Talent graph

The shape of Crinetics Pharmaceuticals's talent

Dealroom maps Crinetics Pharmaceuticals's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

15 team members profilednamed & role-tagged by Dealroom
626 employeestotal headcount
7 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Crinetics Pharmaceuticals's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$79M patent portfolio · 46 active families

Estimated portfolio value
$79M
1.0% of market cap · comparable to top peer Terns Pharmaceuticals ($54M)
46 active patent families
Where Crinetics Pharmaceuticals innovates AgonistAntagonistBiochemistryDiseaseMelanocortin

Where Crinetics Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Crinetics Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Crinetics Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Crinetics Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Crinetics Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles